Company Filing History:
Years Active: 2013
Title: Thorsten Wöhl: Innovator in Antibody Research
Introduction
Thorsten Wöhl is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of antibody research, particularly in the identification of specific amino acid sequences that serve as target epitopes for antibodies.
Latest Patents
Wöhl holds a patent for "Binding epitopes for G250 antibody." This invention relates to specific amino acid sequences that have been determined to be target epitopes for antibodies, especially for the G250 antibody. He has 1 patent to his name, showcasing his innovative work in this specialized area.
Career Highlights
Thorsten Wöhl is associated with Wilex AG, a company that focuses on developing innovative cancer therapies. His work at Wilex AG has allowed him to contribute to advancements in medical research and therapeutic solutions.
Collaborations
Wöhl collaborates with Volker Böttger, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Thorsten Wöhl's contributions to antibody research and his patent for G250 antibody epitopes highlight his role as an innovator in the medical field. His work continues to influence advancements in cancer therapies and antibody development.